Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp.

Journal of Clinical Microbiology

Volumn 44, Issue 6, 2006, Pages 2105-2108

  Sims, Charles R ^a   Paetznick, Victor L ^a   Rodriguez, Jose R ^a   Chen, Enuo ^a   Ostrosky Zeichner, Luis ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; GLUCOSE; METHYLENE BLUE; MUELLER HINTON AGAR; POSACONAZOLE; UNCLASSIFIED DRUG;

ANALYTICAL PARAMETERS; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLINICAL AND LABORATORY STANDARDS INSTITUTE M27 A2 METHOD; CLINICAL AND LABORATORY STANDARDS INSTITUTE M44A METHOD; CONCORDANCE; CORRELATION ANALYSIS; DISK DIFFUSION METHOD; E TEST; FUNGUS GROWTH; GROWTH INHIBITION; INHIBITORY ZONE DIAMETER; INTERMETHOD COMPARISON; INTERPRETATIVE AGREEMENT; LABORATORY TEST; MEASUREMENT; MICRODILUTION METHOD; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEARSON TEST; PRIORITY JOURNAL; REPRODUCIBILITY; STATISTICAL ANALYSIS;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FUNGEMIA; HUMANS; MICROBIAL SENSITIVITY TESTS; TRIAZOLES;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

EID: 33745125061     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02591-05     Document Type: Article

References (17)

1. Arthington-Skaggs, B. A., W. Lee-Yang, M. A. Ciblak, J. P. Frade, M. E. Brandt, R. A. Hajjeh, L. H. Harrison, A. N. Sofair, and D. W. Warnock. 2002. Comparison of visual and spectrophotometric methods of broth microdilution MIC endpoint determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrob. Agents Chemother. 46:2477-2481.
2. Barry, A. L., and S. D. Brown. 1996. Fluconazole disk diffusion procedure for determining susceptibility of Candida species. J. Clin. Microbiol. 34:2154-2157.
3. Clinical Laboratory Standards Institute. 1999. Development of in vitro susceptibility testing criteria and quality control parameters. Approved guideline, 2nd ed, vol. M23-A2. CLSI, Wayne, Pa.
4. Clinical Laboratory Standards Institute. 2002. Method for antifungal disk diffusion susceptibility testing in yeasts. Approved guideline, vol. M44-A. CLSI, Wayne, Pa.
5. Clinical Laboratory Standards Institute. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, vol. M27-A2. CLSI, Wayne, Pa.
6. Espinel-Ingroff, A., M. Pfaller, S. A. Messer, C. C. Knapp, N. Holliday, and S. B. Killian. 2004. Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp. J. Clin. Microbiol. 42:718-721.
7. Gleason, T. G., A. K. May, D. Caparelli, B. M. Farr, and R. G. Sawyer. 1997. Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units. Arch. Surg. 132:1197-1202.
8. Krcmery, V., and A. J. Barnes. 2002. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J. Hosp. Infect. 50:243-260.
9. Matar, M. J., L. Ostrosky-Zeichner, V. L. Paetznick, J. R. Rodriguez, E. Chen, and J. H. Rex. 2003. Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob. Agents Chemother. 47:1647-1651.
10. Metzler, C. M., and R. M. DeHaan. 1974. Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. J. Infect. Dis. 130:588-594.
11. Munayyer, H. K., P. A. Mann, A. S. Chau, T. Yarosh-Tomaine, J. R. Greene, R. S. Hare, L. Heimark, R. E. Palermo, D. Loebenberg, and P. M. McNicholas. 2004. Posaconazole is a potent inhibitor of sterol 14α-demethylation in yeasts and molds. Antimicrob. Agents Chemother. 48:3690-3696.
12. Ostrosky-Zeichner, L., J. H. Rex, P. G. Pappas, R. J. Hamill, R. A. Larsen, H. W. Horowitz, W. G. Powderly, N. Hyslop, C. A. Kauffman, J. Cleary, J. E. Mangino, and J. Lee. 2003. Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob. Agents Chemother. 47:3149-3154.
13. Pfaller, M. A., D. J. Diekema, L. Boyken, S. A. Messer, S. Tendolkar, and R. J. Hollis. 2003. Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole. J. Clin. Microbiol. 41:1875-1880.
14. Pfaller, M. A., S. A. Messer, L. Boyken, R. J. Hollis, C. Rice, S. Tendolkar, and D. J. Diekema. 2004. In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program. Diagn. Microbiol. Infect. Dis. 48:201-205.
15. Pfaller, M. A., S. A. Messer, R. J. Hollis, and R. N. Jones. 2001. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans. Antimicrob. Agents Chemother. 45:2862-2864.
16. Pfaller, M. A., S. A. Messer, K. Mills, A. Bolmstrom, and R. N. Jones. 2001. Evaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida species. J. Clin. Microbiol. 39:3952-3954.
17. Rex, J. H., M. A. Pfaller, T. J. Walsh, V. Chaturvedi, A. Espinel-Ingroff, M. A. Ghannoum, L. L. Gosey, F. C. Odds, M. G. Rinaldi, D. J. Sheehan, and D. W. Warnock. 2001. Antifungal susceptibility testing: practical aspects and current challenges. Clin. Microbiol. Rev. 14:643-658.